期刊文献+

阿奇霉素联合炎琥宁治疗儿童肺炎支原体肺炎的疗效分析 被引量:2

Clinical analysis of azithromycin combined with andrographolide in treating children mycoplasmal pneumonia
下载PDF
导出
摘要 目的分析阿奇霉素联合炎琥宁治疗儿童肺炎支原体肺炎的疗效。方法抽选2013年4月~2014年6月我院收治的肺炎支原体肺炎患儿162例,随机法分为观察组(n=81)和对照组(n=81),对照组患儿给予阿奇霉素治疗,观察组在此基础上加用炎琥宁治疗,用药前先用5%葡萄糖注射液进行冲管。对比两组患儿治疗疗效及临床症状积分改善情况。结果观察组总有效率95.8%,显著高于对照组80.3%,差异有统计学意义(P〈0.05)。观察组临床症状积分治疗1周及治疗后下降至(8.1±4.7)分、(3.2±1.96)分,显著低于对照组(14.2±3.0)分、(8.3±2.4)分,两组相比差异有统计学意义(P〈0.05)。结论阿奇霉素联合炎琥宁治疗儿童肺炎支原体肺炎疗效显著增强,能迅速缓解患儿干咳、咽痛、头痛、发热等临床症状。 Objective: To investigate the clinical effect of azithromycin combined with andrographolide in treating children mycoplasmal pneumonia. Methods- 162 cases with mycoplasmal pneumonia in our hospital from April 2013 to June 2014 were selected. They were divided into observation group (n=81) and control group (n=81). Control group was given azithromycin treatment and observation group was given andrographohde based on control group. The first 3 days, 5% glucose injection was used to wash pipe. Compared the clinical effect and clinical symptoms integral improvement of the two groups. Results: Total effective rate of observation group (95.8%) was obviously higher than control group (80.3%), the difference was statistically significant (P〈0.05). Clinical symptoms integral of observation group dropped to (8.1 ± 4.7 ) score, ( 3.2 ± 1.96 ) score after one week and after treatment, obviously lower than control group ( 14.2 ± 3.0 ) score, ( 8.3 ± 2.4 ) score, the difference was statistically significant (P〈0.05). Conclusion: Azithromycin combined with andrographolide in treating children mycoplasmal pneumonia has significant effect, it can quickly ease the clinical symptoms like dry cough, sore throat, headache, fever and so on.
作者 兰彬
出处 《西藏医药》 2016年第1期1-3,共3页 Tibetan Medicine
关键词 阿奇霉素 炎琥宁 肺炎支原体肺炎 儿童 azithromycin andrographolide mycoplasmal pneumonia children
  • 相关文献

参考文献9

二级参考文献87

  • 1华春珍,俞惠民,陈志敏,李建平,尚世强.流感嗜血杆菌致小儿下呼吸道感染216例分析[J].临床儿科杂志,2005,23(9):624-626. 被引量:10
  • 2陈松柏,杨晶,宋燕.炎琥宁与阿奇霉素联合治疗小儿支原体肺炎[J].航空航天医药,2007,18(1):21-22. 被引量:4
  • 3Matsubara K, Morozumi M, Okada T. A comparative clinical study of macrolide sensitive and m acrolide - resistant Mycoplasma pneumoniae infections in pediatric patients [ J ] J Infect Chemother, 2009, 15 ( 6 ) : 380 - 383.
  • 4Morozumi M,Takahashi T, Ubukata K. Macrolide -resistant Mycoplasma pneumoniae:Charaeteristics of isolates and clinical aspects of community acquired pneumonia[ J]. J Infect Chemother,2010,16 (2) :78 -86.
  • 5胡亚美,江载芳.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2002:632-636.
  • 6陈新谦,金有豫,汤光.新编药物学[M].15版.北京:人民卫生出版社,2004:394,569.
  • 7沈晓明,王卫平.儿科学[M].7版.北京:人民卫生出版社,2008:93.
  • 8胡亚美.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2006:617
  • 9胡亚美,江载芳.小儿实用儿科学[M].北京:人民卫生出版社,2002:1205.
  • 10Hantz S, Gamier F, Peuehant O, et al. Multilocus variable-number tandem-repeat analysis-confirmed emergence of a macrolide resistance-associated mutation in Mycoplasma pneumoniae during macrolide therapy for interstitial pneumonia in an immunocompromised child [J]. J Clin Microbiol,2012,50 (10) : 3402-3405.

共引文献429

同被引文献129

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部